共 50 条
- [21] REAL-WORLD TREATMENT PATTERNS AND PATIENT MANAGEMENT IN UNFIT PATIENTS WITH AML RECEIVING FIRST LINE SYSTEMIC TREATMENT OR BEST SUPPORTIVE CARE (CURRENT): ANALYSIS OF THE ITALIAN STUDY POPULATIONHAEMATOLOGICA, 2021, 106 (10) : 77 - 77Martelli, M. P.Olivieri, A.Di Renzo, N.Curti, A.Fracchiolla, N.Maurillo, L.Gualberti, G.Finsinger, P.D'Attino, R. M.Scalise, L.Ferrara, F.
- [22] Association between Helicobacter pylori infection and mortality risk in prostate cancer patients receiving androgen deprivation therapy: A real-world evidence studyCANCER MEDICINE, 2021, 10 (22): : 8162 - 8171Liu, Jui-MingWu, Chun-TeHsu, Ren-JunHsu, Wen-Lin
- [23] Real-world cost-effectiveness of pertuzumab (P) with trastuzumab plus chemo (T plus Chemo) in patients (pts) with metastatic breast cancer (MBC): A population-based retrospective cohort study by the Canadian Real-world Evidence for Value in Cancer Drugs (CanREValue) collaboration.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Dai, Wei FangBeca, Jaclyn MarieNagamuthu, ChenthilaLiu, NingTrudeau, Maureen E.Earle, CraigDe Oliveira, ClaireChan, Kelvin K.
- [24] A Real-World Evidence Study Evaluating Oral-Health-Related Quality of Life Following the Use of Anti-Sensitivity Toothpaste for Self-Reported Dentine Hypersensitivity ManagementJOURNAL OF CLINICAL PERIODONTOLOGY, 2025,Grimaldi, RobertaBaker, Sarah R.Shah, ParthSanchez, EdwinShanga, GilbertGomez-Pereira, Paola R.Parkinson, Charlie R.
- [25] Frequency, management, and resource use of adverse events (AEs) in nonmetastatic castrate-resistant prostate cancer (nmCRPC) patients receiving apalutamide or enzalutamide: A real-world study.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)Jiang, ShanVarghese, DellaAppukkuttan, SreevalsaCorman, ShelbyKebede, NehemiahGnanasakthy, KajanMacahilig, CynthiaWaldeck, Reginald A.Hussain, Arif
- [26] Changing Rates of Goals of Care Designations in Patients With Advanced Pancreatic Cancer During a Multifactorial Advanced Care Planning Initiative: A Real-World Evidence StudyJCO ONCOLOGY PRACTICE, 2022, 18 (06) : 447 - +Anaka, MatthewLee, MinjiLim, ElisaGhosh, SunitaCheung, Winson Y.Spratlin, Jennifer
- [27] Anti-hypertensives associated with survival in cancer patients receiving immunotherapy: new evidence from a real-world cohort study and meta-analysisTHERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16Ma, PingZhang, ZhihuanQian, MengyingJiang, HaoZhao, YuShan, QingLiu, XiaYao, TianmingGuo, Jinmin
- [28] Real-world patient-reported outcomes of breast cancer or prostate cancer patients receiving antiresorptive therapy for bone metastases: Final results of the PROBone registry studyJOURNAL OF BONE ONCOLOGY, 2022, 33Jakob, AndreasZahn, Mark-OliverNusch, ArndWerner, ThorstenSchnell, RolandFrank, MelanieHamm, NicoleDaessler, Klaus-UlrichLosem, ChristophWelslau, ManfredHoevel, PetraPotthoff, Karin
- [29] Real-World Healthcare Resource Use Associated with Recurrent or Metastatic Head and Neck Cancer Patients Care in Portugal-TRACE StudyCURRENT ONCOLOGY, 2024, 31 (08) : 4270 - 4283Teixeira, Maria MargaridaDias, JoaoAndre, TeresaJoaquim, AnaFernandes, RicardoMagalhaes, JoanaMarreiros, LauraPinto, LeonorRibeiro, LeonorNogueira, MafaldaMorais, Catarina
- [30] Evaluating real-world caregiver involvement from a survey of patients (pts) with metastatic urothelial cancer (mUC) receiving systemic anticancer treatment in France, Germany, Italy, Spain, and the UK (Eu5)ANNALS OF ONCOLOGY, 2022, 33 (07) : S1375 - S1375La Puente, M.Berry, M.Milloy, N.Montgomery, R.Bleasdale, C.Kluth, C.Kirker, M.Kearney, M.Costa, N.Chang, J.